Ronald R Buggage

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 1857, USA
    Ocul Immunol Inflamm 15:63-70. 2007
  2. ncbi Ocular manifestations of human T-cell lymphotropic virus type 1 infection
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Curr Opin Ophthalmol 14:420-5. 2003
  3. ncbi Effect of sex hormones on experimental autoimmune uveoretinitis (EAU)
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Immunol Invest 32:259-73. 2003
  4. ncbi Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series
    Robert B Nussenblatt
    Laboratory of Immunology, National Eye Institute, Bethesda, Maryland 20892, USA
    Ophthalmology 112:764-70. 2005
  5. ncbi Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Ocul Immunol Inflamm 16:29-33. 2008
  6. ncbi Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma
    Dana J Wallace
    Laboratory of Immunology, Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20895 1857, USA, and Department of Ophthalmology, Tokyo Medical and Dental University, Japan
    Invest Ophthalmol Vis Sci 47:2750-6. 2006
  7. ncbi Primary testicular and intraocular lymphomas: two case reports and a review of the literature
    Dana J Wallace
    National Eye Institute/NIH, Bldg. 10, 10 Center Drive, Bethesda, MD 20892, USA
    Surv Ophthalmol 51:41-50. 2006
  8. ncbi Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: successful management with intravitreal injections and monitoring with quantitative PCR
    Philip D Yin
    National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
    J Clin Virol 38:254-9. 2007
  9. ncbi Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
    Robert B Nussenblatt
    The National Eye Institute, Laboratory of Immunology, NIH, Building 10, 10 Center Drive, Bethesda, MD, USA
    J Autoimmun 21:283-93. 2003
  10. ncbi Hypergammaglobulinemia and corneal opacities in patients with human T-cell lymphotrophic virus type-1
    Marena Patronas
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Ophthalmol 142:1088-9. 2006

Collaborators

Detail Information

Publications23

  1. ncbi A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 1857, USA
    Ocul Immunol Inflamm 15:63-70. 2007
    ..To investigate the safety and efficacy of daclizumab (Zenapax, humanized anti-Tac, HAT) in controlling the ocular manifestations of Behçet's disease...
  2. ncbi Ocular manifestations of human T-cell lymphotropic virus type 1 infection
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Curr Opin Ophthalmol 14:420-5. 2003
    ..This report reviews the recent developments and ocular findings reported in patients with HTLV-1-related diseases...
  3. ncbi Effect of sex hormones on experimental autoimmune uveoretinitis (EAU)
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Immunol Invest 32:259-73. 2003
    ..We evaluated the effect of estrogen, progesterone, and testosterone in autoimmune uveoretinitis (EAU), a rodent model of human ocular autoimmune disease...
  4. ncbi Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series
    Robert B Nussenblatt
    Laboratory of Immunology, National Eye Institute, Bethesda, Maryland 20892, USA
    Ophthalmology 112:764-70. 2005
    ....
  5. ncbi Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Ocul Immunol Inflamm 16:29-33. 2008
    ..To describe the clinical course of a patient with multiple recurrences of primary intraocular lymphoma (PIOL)...
  6. ncbi Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma
    Dana J Wallace
    Laboratory of Immunology, Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20895 1857, USA, and Department of Ophthalmology, Tokyo Medical and Dental University, Japan
    Invest Ophthalmol Vis Sci 47:2750-6. 2006
    ..This study examined the expression of the bcl-2 t(14;18) translocation, the bcl-10 gene, and high expression of bcl-6 mRNA in PIOL cells...
  7. ncbi Primary testicular and intraocular lymphomas: two case reports and a review of the literature
    Dana J Wallace
    National Eye Institute/NIH, Bldg. 10, 10 Center Drive, Bethesda, MD 20892, USA
    Surv Ophthalmol 51:41-50. 2006
    ..Clinicians should be suspicious for intraocular lymphoma in patients with a history of testicular lymphoma who present with vitritis or retinal lesions...
  8. ncbi Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: successful management with intravitreal injections and monitoring with quantitative PCR
    Philip D Yin
    National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
    J Clin Virol 38:254-9. 2007
    ..Progressive outer retinal necrosis (PORN) is an ocular disease in individuals with AIDS and is associated with substantial morbidity. The optimal management of PORN and its clinical course in the HAART era is unclear...
  9. ncbi Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
    Robert B Nussenblatt
    The National Eye Institute, Laboratory of Immunology, NIH, Building 10, 10 Center Drive, Bethesda, MD, USA
    J Autoimmun 21:283-93. 2003
    ..These studies suggest that anti-IL-2 receptor blockade could be useful in the treatment of Th1-mediated autoimmune conditions...
  10. ncbi Hypergammaglobulinemia and corneal opacities in patients with human T-cell lymphotrophic virus type-1
    Marena Patronas
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Ophthalmol 142:1088-9. 2006
    ..99). CONCLUSION: Although the mechanism remains unclear, hypergammaglobulinemia is associated with the development of the corneal opacities in patients of African descent with ATL...
  11. ncbi Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma
    Chi Chao Chan
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bldg 10, Rm 10N103, 90 Center Drive, Bethesda, MD 20892 1857, USA
    Ophthalmology 110:421-6. 2003
    ..We investigated the expression of these chemokine/chemokine receptors in eyes with primary intraocular B-cell lymphoma (PIOL)...
  12. ncbi Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome
    Wee-Kiak Lim
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892-1857, USA
    Am J Ophthalmol 139:562-3. 2005
    ..The pathogenesis of uveitis in ALPS may differ from that of the systemic disease overall. Long-term follow-up is required for patients with uveitis associated with ALPS...
  13. ncbi Serpiginous choroiditis
    Wee-Kiak Lim
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA; and Singapore National Eye Centre, Singapore
    Surv Ophthalmol 50:231-44. 2005
    ..Larger clinical studies and interventional trials are required to further our understanding of the pathogenesis, etiology, and for the evaluation of treatment strategies...
  14. ncbi Occult primary carcinoma metastatic to the iris
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Acta Ophthalmol Scand 82:746-7. 2004
  15. ncbi Waldenström's macroglobulinemia-associated retinopathy
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, Room 10N112, 9000 Rockville Pike, Bethesda, MD 20892-1857, USA
    Ophthalmology 111:535-9. 2004
    ..CONCLUSION: The paraneoplastic retinopathy associated with Waldenström's macroglobulinemia in this patient is presumed to result from antibodies of the IgM subtype reacting to proteins in the retinal photoreceptors...
  16. ncbi Gamma interferon assay as an alternative to PPD skin testing in selected patients with granulomatous intraocular inflammatory disease
    Shree K Kurup
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Can J Ophthalmol 41:737-40. 2006
    ....
  17. ncbi Conjunctival papillomas caused by human papillomavirus type 33
    Ronald R Buggage
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892-1857, USA
    Arch Ophthalmol 120:202-4. 2002
  18. ncbi Malignant cerebellar swelling in Behçet disease. Case illustration
    Russell R Lonser
    Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1414, USA
    J Neurosurg 103:292. 2005
  19. ncbi Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis
    Zhuqing Li
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, 10B22, 10 Center Drive, Bethesda, MD 20892 1857, USA
    J Autoimmun 21:83-92. 2003
    ..Therefore, GITR is an activation marker for the CD4+ T cells and preferentially co-expressed with CD25 on the CD4+ T cells in human peripheral blood. Its expression correlates with the clinical course of non-infectious uveitis...
  20. ncbi Intraocular lymphoma
    Chi Chao Chan
    Laboratory of Immunology National Eye Institute, National Institutes of Health, Building 10 Room 10N103, 10 Center Drive, Bethesda, MD 20892 1857, USA
    Curr Opin Ophthalmol 13:411-8. 2002
    ..Compared with PIOL, metastatic systemic lymphomas have a much lower prevalence, better prognosis, and are less likely to create a diagnostic dilemma...
  21. ncbi Mycophenolate mofetil for the treatment of scleritis
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892-1857, USA
    Ophthalmology 110:1750-5. 2003
    ....
  22. ncbi Human T-cell lymphotropic virus type-1 associated t-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis
    Grace A Levy-Clarke
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 109:1717-22. 2002
    ..This case further demonstrates the usefulness of microdissection and PCR for the diagnosis of ocular disease, including HTLV-1 infection...
  23. ncbi Vitreous cytokine levels
    Lesley A Wolf
    Ophthalmology 110:1671-2. 2003